DRUG J2J-MC-JZLB : EMBER-2: A Phase 1, Open-Label, Preoperative Window Study Evaluating the Biological Effects of LY3484356 in Post-menopausal Women with Stage I-III Estrogen Receptor-Positive, HER2-Negative Breast Cancer

Project: Research project

Project Details

StatusFinished
Effective start/end date5/20/21 → 5/20/24

Funding

  • Lilly USA, LLC (DRUG J2J-MC-JZLB)